160 related articles for article (PubMed ID: 10877525)
1. New anti-inflammatory treatment strategy in Alzheimer's disease.
Sugaya K; Uz T; Kumar V; Manev H
Jpn J Pharmacol; 2000 Feb; 82(2):85-94. PubMed ID: 10877525
[TBL] [Abstract][Full Text] [Related]
2. Dual acting anti-inflammatory drugs: a reappraisal.
Bertolini A; Ottani A; Sandrini M
Pharmacol Res; 2001 Dec; 44(6):437-50. PubMed ID: 11735348
[TBL] [Abstract][Full Text] [Related]
3. Dual acting anti-inflammatory drugs.
Leone S; Ottani A; Bertolini A
Curr Top Med Chem; 2007; 7(3):265-75. PubMed ID: 17305569
[TBL] [Abstract][Full Text] [Related]
4. Prevention of thrombosis and vascular inflammation: benefits and limitations of selective or combined COX-1, COX-2 and 5-LOX inhibitors.
de Gaetano G; Donati MB; Cerletti C
Trends Pharmacol Sci; 2003 May; 24(5):245-52. PubMed ID: 12767724
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic role of dual inhibitors of 5-LOX and COX, selective and non-selective non-steroidal anti-inflammatory drugs.
Martel-Pelletier J; Lajeunesse D; Reboul P; Pelletier JP
Ann Rheum Dis; 2003 Jun; 62(6):501-9. PubMed ID: 12759283
[TBL] [Abstract][Full Text] [Related]
6. Relative contribution of acetylated cyclo-oxygenase (COX)-2 and 5-lipooxygenase (LOX) in regulating gastric mucosal integrity and adaptation to aspirin.
Fiorucci S; Distrutti E; de Lima OM; Romano M; Mencarelli A; Barbanti M; Palazzini E; Morelli A; Wallace JL
FASEB J; 2003 Jun; 17(9):1171-3. PubMed ID: 12709408
[TBL] [Abstract][Full Text] [Related]
7. [Cyclooxygenases, lipoxygenases, their targeted drugs and the prevention of Alzheimer's disease].
Shen JN; Xu LX; Wang R
Yao Xue Xue Bao; 2013 Dec; 48(12):1743-54. PubMed ID: 24689230
[TBL] [Abstract][Full Text] [Related]
8. Dual inhibition of 5-LOX and COX-2 suppresses colon cancer formation promoted by cigarette smoke.
Ye YN; Wu WK; Shin VY; Bruce IC; Wong BC; Cho CH
Carcinogenesis; 2005 Apr; 26(4):827-34. PubMed ID: 15637091
[TBL] [Abstract][Full Text] [Related]
9. Cyclooxygenase and inflammation in Alzheimer's disease: experimental approaches and clinical interventions.
Pasinetti GM
J Neurosci Res; 1998 Oct; 54(1):1-6. PubMed ID: 9778144
[TBL] [Abstract][Full Text] [Related]
10. Evidence that 5-lipoxygenase and acetylated cyclooxygenase 2-derived eicosanoids regulate leukocyte-endothelial adherence in response to aspirin.
Fiorucci S; Distrutti E; Mencarelli A; Morelli A; Laufor SA; Cirino G; Wallace JL
Br J Pharmacol; 2003 Aug; 139(7):1351-9. PubMed ID: 12890715
[TBL] [Abstract][Full Text] [Related]
11. Dual inhibitors of cyclooxygenase and 5-lipoxygenase. A new avenue in anti-inflammatory therapy?
Fiorucci S; Meli R; Bucci M; Cirino G
Biochem Pharmacol; 2001 Dec; 62(11):1433-8. PubMed ID: 11728379
[TBL] [Abstract][Full Text] [Related]
12. Cyclooxygenases and 5-lipoxygenase in Alzheimer's disease.
Manev H; Chen H; Dzitoyeva S; Manev R
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):315-9. PubMed ID: 20691748
[TBL] [Abstract][Full Text] [Related]
13. The different inhibitory effects of Huang-Lian-Jie-Du-Tang on cyclooxygenase 2 and 5-lipoxygenase.
Li L; Zeng H; Shan L; Yuan X; Li Y; Liu R; Zhang W
J Ethnopharmacol; 2012 Sep; 143(2):732-9. PubMed ID: 22884869
[TBL] [Abstract][Full Text] [Related]
14. [The role of cyclooxygenases in neurotoxicity of amyloid beta peptides in Alzheimer's disease].
Cakała M; Strosznajder JB
Neurol Neurochir Pol; 2010; 44(1):65-79. PubMed ID: 20358486
[TBL] [Abstract][Full Text] [Related]
15. ER-34122, a novel dual 5-lipoxygenase/cyclooxygenase inhibitor with potent anti-inflammatory activity in an arachidonic acid-induced ear inflammation model.
Horizoe T; Nagakura N; Chiba K; Shirota H; Shinoda M; Kobayashi N; Numata H; Okamoto Y; Kobayashi S
Inflamm Res; 1998 Oct; 47(10):375-83. PubMed ID: 9831321
[TBL] [Abstract][Full Text] [Related]
16. Cyclooxygenase-2 and 5-lipoxygenase converging functions on cell proliferation and tumor angiogenesis: implications for cancer therapy.
Romano M; Claria J
FASEB J; 2003 Nov; 17(14):1986-95. PubMed ID: 14597668
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of COX inhibitors against beta-amyloid-induced neurotoxicity in human neuroblastoma cells.
Ferrera P; Arias C
Neurochem Int; 2005 Dec; 47(8):589-96. PubMed ID: 16169124
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the antiinflammatory activity of a dual cyclooxygenase-2 selective/5-lipoxygenase inhibitor, RWJ 63556, in a canine model of inflammation.
Kirchner T; Argentieri DC; Barbone AG; Singer M; Steber M; Ansell J; Beers SA; Wachter MP; Wu W; Malloy E; Stewart A; Ritchie DM
J Pharmacol Exp Ther; 1997 Aug; 282(2):1094-101. PubMed ID: 9262379
[TBL] [Abstract][Full Text] [Related]
19. Effects of COX1-2/5-LOX blockade in Alzheimer transgenic 3xTg-AD mice.
Bitto A; Giuliani D; Pallio G; Irrera N; Vandini E; Canalini F; Zaffe D; Ottani A; Minutoli L; Rinaldi M; Guarini S; Squadrito F; Altavilla D
Inflamm Res; 2017 May; 66(5):389-398. PubMed ID: 28238167
[TBL] [Abstract][Full Text] [Related]
20. Cyclooxygenase and 5-lipoxygenase inhibitors protect against mononuclear phagocyte neurotoxicity.
Klegeris A; McGeer PL
Neurobiol Aging; 2002; 23(5):787-94. PubMed ID: 12392782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
